Biopsies frequently come back inconclusive due to poor sample quality. Pathware created software solutions to simplify digital pathology workflows and reduce the rate of repeat procedures. Bioptic™, a cloud-based sample management platform, returns a biopsy quality determination in minutes, verifying that a viable biopsy was collected with greater than 90% certainty. The original team included members from the University of Alabama and University of Michigan. They participated in the National Science Foundation I-Corps program in 2016, the E-Team program in 2017, ASPIRE Healthcare at TechTown in 2017, and OPEN Minds in 2018. VentureWell invested in the company in February 2019 alongside Valley Venture Mentors and Unity Point Health.